ATE100717T1 - Intralaesionale behandlung von basalzellenkarzinoma mittels rekombinanten humanen alpha-interferons. - Google Patents
Intralaesionale behandlung von basalzellenkarzinoma mittels rekombinanten humanen alpha-interferons.Info
- Publication number
- ATE100717T1 ATE100717T1 AT87304642T AT87304642T ATE100717T1 AT E100717 T1 ATE100717 T1 AT E100717T1 AT 87304642 T AT87304642 T AT 87304642T AT 87304642 T AT87304642 T AT 87304642T AT E100717 T1 ATE100717 T1 AT E100717T1
- Authority
- AT
- Austria
- Prior art keywords
- cell carcinoma
- recombinant human
- basal cell
- intraaesional
- treatment
- Prior art date
Links
- 206010004146 Basal cell carcinoma Diseases 0.000 title abstract 2
- 102000014150 Interferons Human genes 0.000 title 1
- 108010050904 Interferons Proteins 0.000 title 1
- 229940047124 interferons Drugs 0.000 title 1
- 108010078049 Interferon alpha-2 Proteins 0.000 abstract 1
- 108010047761 Interferon-alpha Proteins 0.000 abstract 1
- 102000006992 Interferon-alpha Human genes 0.000 abstract 1
- 229960003507 interferon alfa-2b Drugs 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- MIXCUJKCXRNYFM-UHFFFAOYSA-M sodium;diiodomethanesulfonate;n-propyl-n-[2-(2,4,6-trichlorophenoxy)ethyl]imidazole-1-carboxamide Chemical compound [Na+].[O-]S(=O)(=O)C(I)I.C1=CN=CN1C(=O)N(CCC)CCOC1=C(Cl)C=C(Cl)C=C1Cl MIXCUJKCXRNYFM-UHFFFAOYSA-M 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/212—IFN-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US86664486A | 1986-05-27 | 1986-05-27 | |
| EP87304642A EP0248583B1 (de) | 1986-05-27 | 1987-05-26 | Intraläsionale Behandlung von Basalzellenkarzinoma mittels rekombinanten humanen alpha-Interferons |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE100717T1 true ATE100717T1 (de) | 1994-02-15 |
Family
ID=25348060
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT87304642T ATE100717T1 (de) | 1986-05-27 | 1987-05-26 | Intralaesionale behandlung von basalzellenkarzinoma mittels rekombinanten humanen alpha-interferons. |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP0248583B1 (de) |
| JP (1) | JPS62289526A (de) |
| KR (1) | KR870010871A (de) |
| AT (1) | ATE100717T1 (de) |
| AU (1) | AU601741B2 (de) |
| CA (1) | CA1295243C (de) |
| DE (1) | DE3788899T2 (de) |
| DK (1) | DK264787A (de) |
| ES (1) | ES2061496T3 (de) |
| IE (1) | IE62318B1 (de) |
| IL (1) | IL82654A0 (de) |
| PH (1) | PH26198A (de) |
| ZA (1) | ZA873743B (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5028422A (en) * | 1986-05-27 | 1991-07-02 | Schering Corporation | Treatment of basal cell carcinoma intralesionally with recombinant human alpha interferon |
| EP0278715A3 (de) * | 1987-02-09 | 1989-03-08 | Schering Corporation | Verwendung von menschlichem Gamma-Interferon für die Behandlung von Basalzell-Karzinomen |
| IL92495A (en) * | 1988-12-01 | 1995-05-26 | Schering Corp | Medicinal product containing recombinant human alpha interphone for the treatment of LLEC SUOMAUQS carcinoma in dose into the tumor |
| US5256410A (en) * | 1988-12-01 | 1993-10-26 | Schering Corporation | Treatment of squamous cell carcinoma intralesionally with recombinant human alpha interferon |
| WO1992011025A2 (en) * | 1990-12-21 | 1992-07-09 | Schering Corporation | Administering alpha interferon by oral inhalation to treat asthma and non-malignant proliferative pulmonary diseases |
| AU2018246292A1 (en) * | 2017-03-31 | 2019-10-10 | Accanis Biotech F&E Gmbh & Co Kg | Prevention and treatment of non-melanoma skin cancer (NMSC) |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3278234D1 (en) * | 1981-10-13 | 1988-04-21 | Exovir Inc | Interferon-containing compositions and the use of these compositions in the treatment of herpetic infections, pre-malignant skin lesions, skin malignancies and psoriasis |
| US5098703A (en) * | 1982-01-15 | 1992-03-24 | Cetus Corporation | Interferon-alpha 76 |
| EP0098864A1 (de) * | 1982-01-15 | 1984-01-25 | Cetus Corporation | Interferon-alpha 74 |
| AU1153083A (en) * | 1982-01-15 | 1983-07-28 | Cetus Corporation | Interferon-alpha 54 |
| US4822605A (en) * | 1986-02-18 | 1989-04-18 | Exovir, Inc. | Compositions and methods employing the same for the treatment of viral and cancerous skin lesions and the like |
| US4853218A (en) * | 1987-02-24 | 1989-08-01 | Schering Corporation | Zinc-protamine-alpha interferon complex |
-
1987
- 1987-05-25 PH PH35292A patent/PH26198A/en unknown
- 1987-05-25 ZA ZA873743A patent/ZA873743B/xx unknown
- 1987-05-25 AU AU73366/87A patent/AU601741B2/en not_active Ceased
- 1987-05-25 IE IE135887A patent/IE62318B1/en not_active IP Right Cessation
- 1987-05-25 CA CA000537837A patent/CA1295243C/en not_active Expired - Lifetime
- 1987-05-25 DK DK264787A patent/DK264787A/da not_active Application Discontinuation
- 1987-05-26 AT AT87304642T patent/ATE100717T1/de not_active IP Right Cessation
- 1987-05-26 ES ES87304642T patent/ES2061496T3/es not_active Expired - Lifetime
- 1987-05-26 JP JP62129563A patent/JPS62289526A/ja active Pending
- 1987-05-26 DE DE87304642T patent/DE3788899T2/de not_active Expired - Fee Related
- 1987-05-26 IL IL82654A patent/IL82654A0/xx not_active IP Right Cessation
- 1987-05-26 KR KR870005198A patent/KR870010871A/ko not_active Ceased
- 1987-05-26 EP EP87304642A patent/EP0248583B1/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| PH26198A (en) | 1992-03-18 |
| DK264787D0 (da) | 1987-05-25 |
| DK264787A (da) | 1987-11-28 |
| ZA873743B (en) | 1987-11-25 |
| JPS62289526A (ja) | 1987-12-16 |
| IE62318B1 (en) | 1995-01-25 |
| CA1295243C (en) | 1992-02-04 |
| KR870010871A (ko) | 1987-12-18 |
| EP0248583B1 (de) | 1994-01-26 |
| ES2061496T3 (es) | 1994-12-16 |
| DE3788899D1 (de) | 1994-03-10 |
| AU7336687A (en) | 1987-12-03 |
| AU601741B2 (en) | 1990-09-20 |
| DE3788899T2 (de) | 1994-05-05 |
| IE871358L (en) | 1987-11-27 |
| EP0248583A2 (de) | 1987-12-09 |
| EP0248583A3 (en) | 1989-10-18 |
| IL82654A0 (en) | 1987-11-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI874706L (fi) | Menetelmä glykosyloimattoman yhdistelmäinterferoni- :n stabiilien, farmaseuttisten koostumusten valmistamiseksi | |
| BG60253B1 (bg) | Човешки тъканен плазминогенен активатор | |
| IL87621A0 (en) | Conjugates of cytokines with immunoglobulins,their preparation and pharmaceutical compositions containing them | |
| BG49827A3 (bg) | Метод за получаване на пречистен биологично активен рекомбинантен човешки колоний стимулиращ фактор | |
| IT8619055A0 (it) | Composizioni farmaceutiche comprendenti peptidi del gruppo colecistochinina-cerulina per il trattamento terapeutico degli statidi shock e dell'insufficienza respiratoria e cardiocircolatoria. | |
| IT1183181B (it) | Derivati del 3-metil-imidazo(4,5-c)pirazolo con attivita' terapeutica e procedimento per la loropreparazione | |
| ATE74272T1 (de) | Pharmazeutischer stoff fuer die behandlung von myelogener leukaemie. | |
| DK0643973T3 (da) | Anvendelse af humant interferon-beta til fremstilling af farmaceutiske præparater til behandling af kronisk myeloid leukæmi | |
| DE3788899D1 (de) | Intraläsionale Behandlung von Basalzellenkarzinoma mittels rekombinanten humanen alpha-Interferons. | |
| ATE174798T1 (de) | Die herstellung von zusammensetzungen zur behandlung von krankheiten der zellproliferation | |
| DE3773295D1 (de) | Homogene rekombinante immun-interferon-fragmente und diese enthaltende pharmazeutische zusammensetzungen. | |
| ES2115582T3 (es) | Preparacion y aplicaciones de interferon-gamma. | |
| DE3861494D1 (de) | Pharmazeutische zusammensetzung zur behandlung von tumoren. | |
| OA08768A (fr) | Traitement du virus su SIDA par l'interféron alpha humain recombinant. | |
| DE68908119D1 (de) | Arzneimittel zur intralesionsbehandlung von schuppenartigem zellkarzinomen mit rekombinantem human-alpha-interferon. | |
| DE3750248D1 (de) | Zubereitung und Behandlung der Haut mit Human-Leukocyten-Interferon. | |
| DE69104619D1 (de) | Verwendungsmethoden von humanem Gammainterferon 4-134. | |
| ATE26267T1 (de) | Pyrimidin-derivate, ausgestattet mit antiviraler wirkung. | |
| FI880891A7 (fi) | Humaanikudoksen plasminogeenin rekombinanttiaktivaattorin koostumus. | |
| KR900012628A (ko) | 감마 인터페론의 유효량을 함유하는 복강내 투여용 난소암 치료제 | |
| ATE54941T1 (de) | Cystein verminderte muteine von biologisch aktiven menschlichen tnf-proteinen. | |
| KR880001300A (ko) | 리트로바이러스 감염의 예방 및 치료를 위한 방법 및 조성물 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |